ANNA HAGHGOOIE

Anna Haghgooie stands as a prominent figure in the healthcare venture capital landscape, serving as a Managing Director at BlueCross BlueShield Venture Partners. In this pivotal role, she is instrumental in identifying, evaluating, and supporting innovative companies poised to revolutionize the healthcare industry. Her work directly contributes to the fund's mission of investing in promising healthcare technology and service companies that aim to improve patient outcomes, enhance care delivery, and drive efficiency across the healthcare ecosystem.

Haghgooie's investment focus is broad yet strategic, encompassing critical areas such as digital health, healthcare information technology, tech-enabled services, and medical devices. She actively seeks out entrepreneurs and companies developing solutions that address pressing challenges within healthcare, from chronic disease management and population health to care coordination and cost reduction. Her expertise lies in recognizing disruptive technologies and business models that can scale and create significant value for both patients and providers.

Before joining BlueCross BlueShield Venture Partners, Anna Haghgooie honed her extensive industry knowledge through a diverse and impactful career. She previously served as a Vice President at Sandbox Industries, the firm that manages the BlueCross BlueShield Venture Partners fund, gaining deep insights into venture capital operations and portfolio management. Prior to her venture capital career, Haghgooie was a Consultant in the healthcare practice at McKinsey & Company, where she advised leading pharmaceutical, medical device, and healthcare services companies on strategic initiatives. Her foundational experience also includes a role as an Analyst in the healthcare investment banking division at Goldman Sachs, providing her with a robust understanding of financial markets and corporate strategy within the healthcare sector. Academically, Anna holds an MBA from Harvard Business School and a BA from Yale University, further solidifying her analytical and leadership capabilities.

Throughout her tenure, Anna Haghgooie has been involved with numerous successful investments that have gone on to achieve significant milestones and exits. While specific current board roles may vary, her past involvement with companies like Livongo Health (acquired by Teladoc), Welltok (acquired by Virgin Pulse), naviHealth (acquired by Optum), and Contessa Health (acquired by Amedisys) highlights her acumen in backing companies that deliver substantial impact and returns. These examples underscore her ability to identify and support ventures that not only innovate but also achieve commercial success and drive meaningful change in healthcare.

Anna Haghgooie's strategic vision and deep industry expertise make her a vital asset to BlueCross BlueShield Venture Partners and the broader healthcare innovation community. She is committed to fostering the growth of companies that are building the future of healthcare, leveraging her experience and the extensive network of the BlueCross BlueShield system to empower entrepreneurs and accelerate the adoption of transformative solutions.